161 related articles for article (PubMed ID: 6246160)
1. Update on drug therapy. IV. Parenteral cephalosporins.
Dahl SL; Elenbaas J; Hamburger S
J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
[No Abstract] [Full Text] [Related]
2. Cefamandole and cefoxitin.
Med Lett Drugs Ther; 1979 Feb; 21(3):13-5. PubMed ID: 310945
[No Abstract] [Full Text] [Related]
3. Use of antibiotics. Cephalosporins.
Wise R
Br Med J; 1978 Jul; 2(6129):40-2. PubMed ID: 678801
[No Abstract] [Full Text] [Related]
4. Newer cephalosporins and cephamycins--a review.
Norrby R
Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
[TBL] [Abstract][Full Text] [Related]
5. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
6. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders W
J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
Fraser DG
Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
[No Abstract] [Full Text] [Related]
8. [Clinico-microbiologic bases for the use of new cephalosporins].
De Bac C; Mascellino MT; Nuti M
Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
[No Abstract] [Full Text] [Related]
9. Intravenous treatment of systemic infections in 20 patients with cefoxitin sodium.
Laplante L; Bastien E; Giroux Y; Girard R
J Antimicrob Chemother; 1978 Jul; 4(B):219-22. PubMed ID: 357391
[No Abstract] [Full Text] [Related]
10. Cefamandole and cefoxitin.
Sanders CV; Greenberg RN; Marier RL
Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
[TBL] [Abstract][Full Text] [Related]
11. [Cefamandel--in-vitro activity and pharmacokinetics].
Simon C; Nixdorf F
Med Welt; 1979 Apr; 30(14):527-30. PubMed ID: 431391
[No Abstract] [Full Text] [Related]
12. The cephalosporins: activity and clinical use.
Weinstein AJ
Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096
[TBL] [Abstract][Full Text] [Related]
13. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
14. Use of cefoxitin sodium in difficult-to-treat infections.
Ramachandran Nair S; Cherubin CE
J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
[No Abstract] [Full Text] [Related]
15. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
[TBL] [Abstract][Full Text] [Related]
16. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
Mirimanoff RO; Héraïef E
Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
[No Abstract] [Full Text] [Related]
17. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
Torres A; Aguirre M; Ales JM
Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
[No Abstract] [Full Text] [Related]
18. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
Mader JT; Wilson KJ
J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
[No Abstract] [Full Text] [Related]
20. The cephalosporin antibiotics in pediatric therapy.
Eichenwald HF; Schmitt HJ
Eur J Pediatr; 1986 Apr; 144(6):532-8. PubMed ID: 3519228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
